Raphael Catane

An implant releasing the gonadotropin hormone-releasing hormone agonist histrelin maintains medical castration for up to 30 months in metastatic prostate cancer.

B. Chertin, A. Farkas, T. Lindenberg, 2000, The Journal of urology.